Roche Holding AG (RHHBF)
422.84
-12.90
(-2.96%)
USD |
OTCM |
Oct 08, 16:00
Roche Market Cap : 336.91B for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 336.91B |
| October 07, 2026 | 347.19B |
| October 06, 2026 | 341.01B |
| October 05, 2026 | 334.58B |
| October 02, 2026 | 334.58B |
| October 01, 2026 | 338.63B |
| September 30, 2026 | 341.58B |
| September 29, 2026 | 339.62B |
| September 28, 2026 | 364.92B |
| September 25, 2026 | 346.39B |
| September 24, 2026 | 364.92B |
| September 23, 2026 | 366.71B |
| September 22, 2026 | 361.60B |
| September 21, 2026 | 354.53B |
| September 18, 2026 | 354.53B |
| September 17, 2026 | 356.97B |
| September 16, 2026 | 341.21B |
| September 15, 2026 | 345.80B |
| September 14, 2026 | 345.80B |
| September 11, 2026 | 345.00B |
| September 10, 2026 | 345.00B |
| September 09, 2026 | 358.54B |
| September 08, 2026 | 358.54B |
| September 04, 2026 | 351.69B |
| September 03, 2026 | 351.69B |
| Date | Value |
|---|---|
| September 02, 2026 | 351.69B |
| September 01, 2026 | 347.79B |
| August 31, 2026 | 361.56B |
| August 28, 2026 | 363.74B |
| August 27, 2026 | 367.29B |
| August 26, 2026 | 372.09B |
| August 25, 2026 | 382.45B |
| August 24, 2026 | 372.97B |
| August 21, 2026 | 372.97B |
| August 20, 2026 | 370.50B |
| August 19, 2026 | 366.09B |
| August 18, 2026 | 350.58B |
| August 17, 2026 | 356.58B |
| August 14, 2026 | 353.51B |
| August 13, 2026 | 363.23B |
| August 12, 2026 | 363.23B |
| August 11, 2026 | 368.05B |
| August 10, 2026 | 367.56B |
| August 07, 2026 | 352.45B |
| August 06, 2026 | 343.54B |
| August 05, 2026 | 346.98B |
| August 04, 2026 | 358.45B |
| August 03, 2026 | 339.29B |
| July 31, 2026 | 337.19B |
| July 30, 2026 | 338.68B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 261.97B |
| GSK Plc | 94.14B |
| Merck & Co., Inc. | 351.49B |
| AstraZeneca PLC | 492.48B |
| Eli Lilly & Co. | 1.101T |
Market Cap Related Metrics
| PE Ratio | 21.87 |
| PS Ratio | 4.431 |
| PEG Ratio | 0.7336 |
| Price to Free Cash Flow | 20.79 |
| Price | 422.84 |
| Earnings Yield | 4.57% |
| PEGY Ratio | 0.6615 |
| Operating PE Ratio | 14.45 |
| Normalized PE Ratio | 18.32 |